Atlas Trials

Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge Model

Clinical trial NCT07503405 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07503405
Sponsor
Traws Pharma, Inc.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Influenza
Start date
2026-06-01
Primary completion
2026-11-01
Enrollment
165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.